云南高校图书馆联盟文献共享服务平台- RIFAXIMIN

RIFAXIMIN: 作品数：55被引量：289H指数：11; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：任淑萍陈瑞玲更多>>; 相关机构：首都医科大学附属北京天坛医院南昌大学更多>>; 相关期刊：《国外药讯》《World Journal of Hepatology》《Open Journal of Gastroenterology》《Current Medical Science》更多>>; 相关基金：国家自然科学基金更多>>

Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt:A meta-analysis: 《World Journal of Hepatology》2025年第4期120-136,共17页Xiao-Tong Xu Min-Jie Jiang Yun-Lai Fu Fang Xie Jian-Jun Li Qing-Hua Meng; BACKGROUND Hepatic encephalopathy(HE)is a primary complication following transjugular intrahepatic portosystemic shunt(TIPS),but the utility of pharmacological prophylaxis for HE is unclear.AIM To assess the HE incide...; 关键词：Transjugular intrahepatic portal shunt Hepatic encephalopathy CIRRHOSIS Prevention LACTULOSE RIFAXIMIN

Rifaximin-αuse is associated with improved muscle mass in patients with cirrhosis: 《World Journal of Hepatology》2025年第4期43-52,共10页Thomas Worland Penelope Hey Darren Wong Ross Apostolov Roseanne Kimberley Chan Marie Sinclair Paul Gow; Supported by Norgine,the marketing authorization holder of rifaximin-α(Xifaxan©).; BACKGROUND Sarcopaenia is associated with a two-fold higher mortality rate in patients with cirrhosis independent of liver disease severity.Few treatments for cirrhosis related sarcopaenia exist beyond optimal nutriti...; 关键词：RIFAXIMIN ENCEPHALOPATHY CIRRHOSIS Liver transplantation Sarcopaeni

Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy: 《World Journal of Hepatology》2024年第11期1356-1360,共5页Lorenzo Ridola Alessandro Mari; Hepatic encephalopathy(HE)is one of the main complications of cirrhosis,characterized by a wide spectrum of neuropsychiatric alterations that lead to an increase in mortality,morbidity and recurrent hospitalizations.D...; 关键词：Hepatic encephalopathy Rifaximin discontinuation Broad-spectrum antibiotics Critically ill patients Intensive care unit

Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment?被引量：1: 《World Journal of Hepatology》2024年第2期115-119,共5页Chien-Hao Huang Piero Amodio; Supported by the Chang Gung Medical Research Project,No.CMRPG3M1931-1932;the National Science and Technology Council,No.MOST 110-2314-B-182A-093-and No.NMRPG3L0331.; Hepatic encephalopathy(HE)is a formidable complication in patients with decompensated cirrhosis,often necessitating the administration of rifaximin(RFX)for effective management.RFX,is a gut-restricted,poorly-absorbabl...; 关键词：Rifaximin discontinuation Hepatic encephalopathy Broad-spectrum antibiotics Crit-ically ill Medical intensive care unit Pharmacist-driven protocol

Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease被引量：2: 《World Journal of Hepatology》2024年第1期75-90,共16页Matheus Truccolo Michalczuk Larisse Longo Melina Belén Keingeski Bruno de Souza Basso Gabriel Tayguara Silveira Guerreiro Jessica T Ferrari JoséEduardo Vargas Cláudia P Oliveira Carolina Uribe-Cruz Carlos Thadeu Schmidt Cerski Eduardo Filippi-Chiela Mário ReisÁlvares-da-Silva; Supported by the following Brazilian funding agencies:Financiamento e IncentivoàPesquisa from Hospital de Clínicas de Porto Alegre(FIPE/HCPA),No.2021-0105(toÁlvares-da-Silva MR);Coordination for the Improvement of Higher Education Personnel,CAPES/PNPD;and this study was financed in part by the Conselho Nacional de Desenvolvimento Científico e Tecnológico(CNPq)(toÁlvares-da-Silva MR).; BACKGROUND Prevalence of hepatocellular carcinoma(HCC)is increasing,especially in patients with metabolic dysfunctionassociated steatotic liver disease(MASLD).AIM To investigate rifaximin(RIF)effects on epigenetic/aut...; 关键词：Animal model AUTOPHAGY Epigenetic Hepatocellular carcinoma Metabolic dysfunction-associated steatotic liver disease RIFAXIMIN

Rifaximin Prevents Intestinal Barrier Dysfunction and Alleviates Liver Injury in MCT-induced HSOS Mice被引量：1: 《Current Medical Science》2023年第6期1183-1194,共12页Yan-yun SHU Li-lin HU Ling YANG Hui-kuan CHU Jin YE Yu JIN; the National Natural Science Foundation of China(No.81800480 and NO.81770582);the Graduates’Innovation Fund,Huazhong University of Science and Technology(No.2021yjsCXCY106).; Objective Rifaximin is an effective component of treatment strategies for liver and intestinal diseases.However,the efficacy of rifaximin in hepatic sinusoidal obstruction syndrome(HSOS)has not been explored.The prese...; 关键词：RIFAXIMIN hepatic sinusoidal obstruction syndrome intestinal barrier tight junction proteins INFLAMMATION

Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy被引量：2: 《World Journal of Hepatology》2023年第11期1226-1236,共11页Jessica A Ward Jason Yerke Mollie Lumpkin Aanchal Kapoor Christina C Lindenmeyer Stephanie Bass; BACKGROUND Rifaximin is frequently administered to critically ill patients with liver disease and hepatic encephalopathy,but patients currently or recently treated with antibiotics were frequently excluded from studie...; 关键词：RIFAXIMIN Hepatic encephalopathy Critical illness ANTIBIOTICS Liver disease CIRRHOSIS

Rifaximin in the Treatment of Gastroesophageal Reflux Disease: A New Idea Based on the Relationship between Intestinal Microecology and Gastroesophageal Reflux Disease被引量：1: 《International Journal of Clinical Medicine》2023年第3期175-184,共10页Di Yang Guangyang Zheng Peilong Wang Lei Huang; Rifaximin in the Treatment of Gastroesophageal Reflux Disease (GERD) is a common clinical disorder, the most common symptom of which is a burning sensation behind the breastbone (heartburn) or reflux of stomach conten...; 关键词：Gastroesophageal Reflux Disease Intestinal Microecology RIFAXIMIN

Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy被引量：1: 《World Journal of Gastroenterology》2023年第1期61-74,共14页Seohyuk Lee Saad Saffo; Cirrhosis is a leading cause of morbidity and mortality,impacting more than 120 million people worldwide.Although geographic differences exist,etiologic factors such as alcohol use disorder,chronic viral hepatitis inf...; 关键词：CIRRHOSIS Hepatic decompensation BETA-BLOCKERS STATINS Sodium-glucose cotransporter-2 inhibitors RIFAXIMIN

Effects of Low-dose and High-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy被引量：4: 《Journal of Clinical and Translational Hepatology》2022年第6期1099-1106,共8页Wei Tan Jian Wang Pei-Mei Shi Ling-Mei Feng Jian Shi Bei-Fang Ning Zong-Li Yuan Xin Zeng Wei-Fen Xie; Background and Aims:Rifaximin is effective in prevent-ing and treating hepatic encephalopathy(HE).This study aimed to investigate the efficacy and safety of different dosages of rifaximin in the treatment of cirrhotic...; 关键词：Single-center open-label study Randomized prospective study Liver cirrhosis Covert hepatic encephalopathy RIFAXIMIN

RIFAXIMIN